Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Thomas Warner from Proactive London after the pharmaceutical company announced another milestone in its global expansion efforts.
Barder shares the news that the Futura has reached an agreement to expand its presence in the Latin America. Initially, Futura Medical had been working with key markets in Mexico and Brazil, and their agreement with local partner M8 Pharmaceuticals confirmed their interest in expanding to the rest of Latin America. The deal follows others in markets around the world.
Barder mentions that the company has received regulatory approval in Mexico and is preparing for its launch there, and they anticipate several more launches in the coming months. The company remains on track to execute up to 10 launches between now and the end of April.
He acknowledges the frustration among shareholders due to the declining share price in recent months. He attributed this decline, in part, to macroeconomic factors and interest rate uncertainty.
While the company is actively exploring ways to address this issue, Barder emphasises that the primary focus remains on product commercialisation and expansion. Despite the share price challenges, Barder says that Futura Medical maintains a robust balance sheet and is fully funded to support its ongoing growth initiatives.